Incomplete Lupus

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Patients who meet less than four American College of Rheumatology (ACR) criteria or have other representative, noncriteria systemic lupus erythematosus (SLE) manifestations have incomplete lupus erythematosus. The most common clinical manifestations in patients with incomplete lupus include rashes, arthritis, Raynaud's phenomenon, and cytopenias. ANA (anti-nuclear antibodies) is the most commonly detected serological finding, but the presence of anti-dsDNA, anti-phospholipid antibodies, and low complements is associated with higher risk of progression to SLE. Despite a generally mild clinical course without nephritis, vasculitis, or CNS involvement, the disease-related mortality and cardiovascular morbidity are indistinguishable from the one in SLE, indicating a need for continued monitoring, vigilance in recognizing this entity, and consideration of early start of treatment.

Original languageEnglish (US)
Title of host publicationSystemic Lupus Erythematosus
Subtitle of host publicationBasic, Applied and Clinical Aspects
PublisherElsevier Inc.
Pages463-466
Number of pages4
ISBN (Electronic)9780128020098
ISBN (Print)9780128019177
DOIs
Publication statusPublished - Jan 1 2016
Externally publishedYes

    Fingerprint

Keywords

  • American College of Rheumatology
  • Epidemiology
  • Incomplete lupus
  • Undifferentiated connective tissue disease

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Stojan, G. (2016). Incomplete Lupus. In Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects (pp. 463-466). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-801917-7.00052-8